Thanks! I like this part: Brilacidin-Otic has sho
Post# of 72440
Brilacidin-Otic has shown excellent results in labratory testing of middle ear (otitis media) infection. Cellceutix intends to develop Brilacidin-Otic, currently undergoing ototoxicity testing in preparation for a clinical trial, as a topical solution to treat acute otitis media infections that drain into the external ear canal, including acute otitis externa and those that occur through a ruptured tympanic membrane or indwelling PE tube.
Upon FDA approval Brilacidin will become a household name.